The Kyoto-based healthcare services firm saw its group revenue reach ¥32.78 billion, a slight increase from the ¥32.73 billion reported in the previous fiscal year. While the top-line growth was modest, the company demonstrated stronger performance in its core profitability metrics. Operating profit climbed to ¥1.75 billion, up from ¥1.66 billion, while pretax profit reached ¥1.91 billion.

Growth in Shareholder Returns

Earnings per share (EPS) showed a notable improvement during the period. The company reported basic earnings per share of ¥140.51, compared to ¥128.82 in the prior year. Diluted earnings per share followed a similar trajectory, rising to ¥139.96 from ¥128.29. This increase reflects the firm's ability to extract more value for shareholders despite a competitive market environment.

Key performance indicators for the nine-month period include:

• Total group revenue of ¥32.78 billion.
• Operating profit growth of approximately 5.4% year-over-year.
• A net profit margin maintained at roughly 4.3%.

The results were prepared in accordance with Japanese accounting standards. Falco Holdings continues to maintain a stable financial position as it enters the final quarter of its fiscal year, balancing consistent revenue streams with controlled operating costs.